Company: LHI
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006939
Chunk: 22

Company: Living Homeopathy International Ltd.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 22
---
 are currently not required to obtain
any permission or approval from the CAC or any other governmental authorities of mainland China to operate our business or to list Living
Homeopathy’s securities on the U.S. exchanges and offer securities, nor have we been denied of any permissions or approvals from
the authorities of mainland China.

Subject to final determination by the
CSRC and relevant competent authorities, Han Kun Law Offices, our PRC counsel, has advised us that based on the facts that (i)
we do not operate any entities in mainland China and the operating revenue, total profit, total assets or net assets as documented
in our audited consolidated financial statements for the most recent fiscal year is accounted for by our Hong Kong subsidiary
located outside mainland China; (ii) except for the operation of our virtual flagship store on Tmall Global, an e-commerce platform
for international businesses to directly sell our brand-name goods to consumers in mainland China, which was recently set up in June
2024 and has not generated sales to consumers in mainland China, as of the date of this prospectus, our business operations are
conducted in Hong Kong, and our senior management team are not PRC citizens and have their residence located outside mainland
China, t we do not meet the criteria as set forth in Article 15 of the Overseas Listing Trial Measures, and are not required to
fulfill the filing procedures with the CSRC to list our securities on a U.S. securities exchange or issue securities to foreign
investors. However, as the Overseas Listing Trial Measures were newly published, there are substantial uncertainties that the CSRC
may take a view that is contrary to our understanding of the Overseas Listing Trial Measures because the CSRC may have substantial
discretions over the determination of “indirect overseas offering and listing by a domestic company”.

Han Kun Law Offices LLP, our Hong Kong counsel, has advised us that, as of the date of this prospectus, Living Homeopathy is not required to obtain any permission or approval from the governmental authorities of Hong Kong to list on the U.S. exchanges and offer securities.

However, if we (i) do not receive or maintain
such permissions or approvals, should such permissions or approvals be required in the future by the PRC or Hong Kong government, (ii)
inadvertently conclude that such permissions or approvals are not required, or (iii) applicable laws, regulations, or interpretations
change and we are required to obtain such permissions or approvals in the future, we may